A

Aundrietta D. Duncan

Io Therapeutics (United States)

ORCID: 0000-0002-1094-4844

Publishes on Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation. 21 papers and 195 citations.

PubIndex Score4Top 96% · seniorHow it's scored

21Publications

195Total Citations

First publication: 2011First senior author: 2011

Ubiquitin and proteasome pathways Protein Degradation and Inhibitors Epigenetics and DNA Methylation Cancer-related Molecular Pathways Histone Deacetylase Inhibitors Research

Top publicationsby citations

TRIM24 Is a p53-Induced E3-Ubiquitin Ligase That Undergoes ATM-Mediated Phosphorylation and Autodegradation during DNA Damage

Abhinav K. Jain, Michelle Barton, Kendra Allton et al.|Molecular and Cellular Biology|2014

Cited by 106

Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer

Vrutant Shah, Michelle Barton, Lei Huo et al.|Nature Communications|2021

Cited by 43

Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children

Andrew D.J. Pearson, Gilles Vassal, Kimberly Stegmaier et al.|European Journal of Cancer|2020

Cited by 25

Sample Preparation for Mass Cytometry Analysis

Ryan L. McCarthy, Michelle Barton, Aundrietta D. Duncan|Journal of Visualized Experiments|2017

Cited by 9

Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins

Galen Rask, Emily R. Theisen, Cenny Taslim et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024

Cited by 3